Phosphoproteomic Characterization and Kinase Signature Predict AML Patients Response to Venetoclax plus 3+7 Daunorubicin and Cytarabine Chemotherapy
| Title | Phosphoproteomic Characterization and Kinase Signature Predict AML Patients Response to Venetoclax plus 3+7 Daunorubicin and Cytarabine Chemotherapy |
|---|---|
| Description | To elucidate the underlying mechanistic determinants governing the response to DAV in AML, we adopted an exhaustive quantitative phosphoproteomics to discern distinct molecular signatures characterizing the subset of DAV-sensitive patients. |
| Organism | Homo sapiens |
| Data Type | Proteomic Data by Mass Spectrometry (MS) |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA019008 |
| Release Date | 2024-02-02 |
| Submitter | Yinghui Zhu (zhuyinghui1989@hotmail.com) |
| Organization | Tongji University |
| Submission Date | 2023-08-12 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX004738-01 | Total identified proteins | 1 | Proteomic Data by Mass Spectrometry (MS) | 11.4 MB | xlsx | 0 | Controlled |
| OMIX004738-02 | Total differential proteins | 1 | Proteomic Data by Mass Spectrometry (MS) | 287.8 KB | xlsx | 0 | Controlled |